General Diligence. Licensee will use Commercially Reasonable Efforts to clinically develop, obtain Regulatory Approval and commercialize at least one Licensed Product in each of the three (3) Subfields within the Field in the Major Markets.
Appears in 3 contracts
Samples: License Agreement (Ultragenyx Pharmaceutical Inc.), License Agreement (Dimension Therapeutics, Inc.), License Agreement (Dimension Therapeutics, Inc.)
General Diligence. Licensee will use Commercially Reasonable Efforts to clinically develop, obtain Regulatory Approval and commercialize at least one (1) Product for each Licensed Product in each of the three Indication selected by Licensee pursuant to Section 2.7 (3) Subfields within the Field in the Major Markets“General Diligence”).
Appears in 3 contracts
Samples: License Agreement, License Agreement (BioNTech SE), License Agreement (BioNTech SE)
General Diligence. Licensee will use Commercially Reasonable Efforts to clinically actively develop, obtain Regulatory Approval and commercialize at least one Licensed Product in each of the three (3) Subfields Indication within the Field in the Major Marketsof Use.
Appears in 3 contracts
Samples: License Agreement (Passage BIO, Inc.), License Agreement (Passage BIO, Inc.), License Agreement (Passage BIO, Inc.)
